Internal Medicine, Gastroenterology · Salina, KS
NPI
1720043045
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
520 S Santa Fe Ave Ste 240
Salina, KS, 67401
Phone (785) 452-6440
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
3,318 services
Medicare patients, 2024
1,470
Average age 73
Drug cost, 2024
$2.4M
3,546 prescriptions
Company payments, 2025
$553
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul A Johnson was code 99213 (office e&m - established), 435 times for 353 patients. In total Paul A Johnson billed 3,318 services in 128 codes, and Medicare paid $254K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 435 | 353 | $58.83 | $26K |
| 43239 Upper GI Endoscopy | Facility | 373 | 347 | $70.30 | $26K |
| 45380 Lower GI Endoscopy - Other | Facility | 283 | 281 | $126.68 | $36K |
| 36415 Venipuncture Blood Collection | Office | 159 | 112 | $8.57 | $1,363 |
| 43235 Upper GI Endoscopy | Facility | 141 | 129 | $78.94 | $11K |
| 43450 Digestive/Gastrointestinal | Facility | 136 | 118 | $29.36 | $3,993 |
| 45385 Colonoscopy - Lesion Removal | Facility | 117 | 117 | $182.77 | $21K |
| 45378 Lower GI Endoscopy - Other | Facility | 109 | 109 | $115.57 | $13K |
| 85025 Blood Count | Office | 99 | 80 | $7.58 | $751 |
| 99222 Hospital E&M - Initial | Facility | 98 | 95 | $96.26 | $9,433 |
| 80053 Clinical Chemistry | Office | 98 | 79 | $10.32 | $1,011 |
| 99212 Office E&M - Established | Office | 80 | 59 | $33.83 | $2,706 |
| 99232 Hospital E&M - Subsequent | Facility | 79 | 48 | $58.30 | $4,605 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 79 | 79 | $164.50 | $13K |
| 43249 Upper GI Endoscopy | Facility | 66 | 52 | $98.86 | $6,524 |
By year: 2022 $278K for 3,704 services; 2023 $274K for 3,705 services; 2024 $254K for 3,318 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 159 | 112 | $8.57 | $1,363 |
| 85025 Blood Count | 99 | 80 | $7.58 | $751 |
| 80053 Clinical Chemistry | 98 | 79 | $10.32 | $1,011 |
| 82274 Immunoassay | 53 | 52 | $15.38 | $815 |
| 85610 Clinical Chemistry | 40 | 30 | $4.20 | $168 |
| 87493 Infectious Agent Detection by DNA/RNA | 29 | 25 | $36.52 | $1,059 |
| 80076 Clinical Chemistry | 24 | 12 | $8.01 | $192 |
| 83550 Clinical Chemistry | 19 | 18 | $8.57 | $163 |
| 83540 Clinical Chemistry | 19 | 18 | $6.34 | $120 |
| 82728 Clinical Chemistry | 17 | 16 | $13.36 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul A Johnson prescribed most often to Medicare patients was Pantoprazole Sodium, with 789 prescriptions and refills. In total Paul A Johnson wrote 3,546 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 789 | 1,885 | 254 | $8,813 |
| Colesevelam Hcl Generic | 218 | 254 | 46 | $11K |
| Mesalamine Generic | 168 | 189 | 29 | $47K |
| Famotidine Generic | 165 | 300 | 41 | $1,406 |
| Omeprazole Generic | 133 | 298 | 36 | $1,186 |
| Mesalamine Er Mesalamine | 130 | 149 | 18 | $26K |
| Colestipol Hcl Generic | 118 | 138 | 26 | $6,014 |
| Budesonide Dr Budesonide | 113 | 157 | 32 | $21K |
| Linzess Linaclotide | 102 | 114 | 21 | $59K |
| Creon Lipase/Protease/Amylase | 101 | 111 | 23 | $202K |
| Ursodiol Generic | 94 | 140 | 15 | $12K |
| Metoclopramide Hcl Generic | 94 | 110 | 25 | $563 |
| Levofloxacin Generic | 76 | 76 | 57 | $78.25 |
| Dicyclomine Hcl Generic | 72 | 89 | 15 | $2,035 |
| Sucralfate Generic | 62 | 72 | 18 | $1,332 |
Brand drugs: 727 claims; generic drugs: 2,819 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul A Johnson $553 ($553 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $144 |
| Stryker Corporation SYK | 1 | $93.9 |
| Lilly USA, LLC LLY | 2 | $51.11 |
| Janssen Biotech, Inc. JNJ | 2 | $48.25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $47.88 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $35.18 |
| Madrigal Pharmaceuticals MDGL | 2 | $35.18 |
| Medtronic, Inc. MDT | 1 | $22.21 |
| Pfizer Inc. PFE | 1 | $20.86 |
| Novo Nordisk Inc NVO | 1 | $19.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.